Review
Published on 23 Sep 2022
On-Target Side Effects of Targeted Therapeutics of Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610694
Type at least 3 characters
2,905 articles
Articles
Hypothesis & Theory
Published on 21 Sep 2022
Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610558
Original Research
Published on 21 Sep 2022
Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
Pathology and Oncology Research
doi 10.3389/pore.2022.1610659
Original Research
Published on 20 Sep 2022
Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics
Pathology and Oncology Research
doi 10.3389/pore.2022.1610572
Original Research
Published on 16 Sep 2022
Identification of Diagnostic Exosomal LncRNA-miRNA-mRNA Biomarkers in Colorectal Cancer Based on the ceRNA Network
Pathology and Oncology Research
doi 10.3389/pore.2022.1610493
Hypothesis & Theory
Published on 15 Sep 2022
Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes
Pathology and Oncology Research
doi 10.3389/pore.2022.1610641
Case Report
Published on 12 Sep 2022
Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion
Pathology and Oncology Research
doi 10.3389/pore.2022.1610570
Correction
Published on 08 Sep 2022
Erratum: The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis
Pathology and Oncology Research
doi 10.3389/pore.2022.1610756
Original Research
Published on 08 Sep 2022
The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients
Pathology and Oncology Research
doi 10.3389/pore.2022.1610550
Original Research
Published on 06 Sep 2022
The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator
Pathology and Oncology Research
doi 10.3389/pore.2022.1610663
Original Research
Published on 06 Sep 2022
Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry
Pathology and Oncology Research
doi 10.3389/pore.2022.1610668
Original Research
Published on 30 Aug 2022
Enhancing Natural Killer Cell-Mediated Cancer Immunotherapy by the Biological Macromolecule Nocardia rubra Cell-Wall Skeleton
Pathology and Oncology Research
doi 10.3389/pore.2022.1610555
Original Research
Published on 30 Aug 2022
Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610635
Original Research
Published on 30 Aug 2022
Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
Pathology and Oncology Research
doi 10.3389/pore.2022.1610559
Original Research
Published on 30 Aug 2022
IL-33 Participates in the Development of Esophageal Adenocarcinoma
Pathology and Oncology Research
doi 10.3389/pore.2022.1610474
Original Research
Published on 30 Aug 2022
O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer
Pathology and Oncology Research
doi 10.3389/pore.2022.1610554